Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

953 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated.
Bladé J, San Miguel JF, Fontanillas M, Alcalá A, Maldonado J, García-Conde J, Conde E, Conzález-Brito G, Moro MJ, Escudero ML, Trujillo J, Pascual A, Rozman C, Estapé J, Montserrat E. Bladé J, et al. Among authors: maldonado j. J Clin Oncol. 1996 Jul;14(7):2167-73. doi: 10.1200/JCO.1996.14.7.2167. J Clin Oncol. 1996. PMID: 8683251 Clinical Trial.
Treatment of multiple myeloma in elderly people: long-term results in 178 patients.
Bladé J, Muñoz M, Fontanillas M, San Miguel J, Alcalá A, Maldonado J, Besses C, Moro MJ, García-Conde J, Rozman C, Montserrat E, Estapé J. Bladé J, et al. Among authors: maldonado j. Age Ageing. 1996 Sep;25(5):357-61. doi: 10.1093/ageing/25.5.357. Age Ageing. 1996. PMID: 8921139 Clinical Trial.
CHOP vs. ProMACE-CytaBOM in the treatment of aggressive non-Hodgkin's lymphomas: long-term results of a multicenter randomized trial.(PETHEMA: Spanish Cooperative Group for the Study of Hematological Malignancies Treatment, Spanish Society of Hematology).
Montserrat E, García-Conde J, Viñolas N, López-Guillermo A, Hernández-Nieto L, Zubizarreta A, Maldonado J, Alcalá A, Faura MV, Llorente A, Bladé J, Fontanillas M, Estapé J. Montserrat E, et al. Among authors: maldonado j. Eur J Haematol. 1996 Nov;57(5):377-83. doi: 10.1111/j.1600-0609.1996.tb01396.x. Eur J Haematol. 1996. PMID: 9003479 Clinical Trial.
[Comparison of chemotherapy CHOP vs. CHOP/VIA in the treatment of aggressive non-Hodgkin's lymphoma: a randomized multicenter study of 132 patients. The PETHEMA group. Program for Study and Therapeutics of malignant hemopathies. Spanish Association of Hematology and Hemotherapy].
López-Guillermo A, García-Conde J, Alvarez-Carmona AM, León P, Maldonado J, Alcalá A, Zubizarreta A, Sancho-Tello R, Carbonell F, Contreras E, Besses C, Hernando A, Fontanillas M, Montserrat E. López-Guillermo A, et al. Among authors: maldonado j. Med Clin (Barc). 1998 May 9;110(16):601-4. Med Clin (Barc). 1998. PMID: 9656196 Clinical Trial. Spanish.
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.
Bladé J, San Miguel JF, Fontanillas M, Esteve J, Maldonado J, Alcalá A, Brunet S, García-Conde J, Besalduch J, Moro MJ, Fernández-Calvo J, Conde E, Font L, Gardella S, Carnero M, Carbonell F, Martí JM, Hernández-Martín J, Ortega F, Besses C, Ribera JM, Trujillo J, Escudero ML, Rozman C, Estapé J, Montserrat E. Bladé J, et al. Among authors: maldonado j. Hematol J. 2001;2(4):272-8. doi: 10.1038/sj.thj.6200115. Hematol J. 2001. PMID: 11920260 Clinical Trial.
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Ribera JM, Ortega JJ, Oriol A, Fontanillas M, Hernández-Rivas JM, Brunet S, García-Conde J, Maldonado J, Zuazu J, Gardella S, Besalduch J, León P, Macià J, Domingo-Albós A, Feliu E, San Miguel JF. Ribera JM, et al. Among authors: maldonado j. Haematologica. 1998 Mar;83(3):222-30. Haematologica. 1998. PMID: 9573676 Clinical Trial.
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?
San Miguel JF, Lahuerta JJ, García-Sanz R, Alegre A, Bladé J, Martinez R, García-Laraña J, De La Rubia J, Sureda A, Vidal MJ, Escudero A, Pérez-Esquiza E, Conde E, García-Ruiz JC, Cabrera R, Caballero D, Moraleda JM, Leon A, Besalduch J, Hernandez MT, Rifon J, Hernandez F, Solano C, Palomera L, Parody R, Gonzalez JD, Mataix R, Maldonado J, Constela J, Carrera D, Bello JL, De Pablos JM, Pérez-Simón JA, Torres JP, Olanguren J, Prieto E, Acebede G, Peñarrubia MJ, Torres P, Díez-Martín JL, Rivas A, Sánchez JM, Díaz-Mediavilla J. San Miguel JF, et al. Among authors: maldonado j. Hematol J. 2000;1(1):28-36. doi: 10.1038/sj.thj.6200003. Hematol J. 2000. PMID: 11920166
953 results